Figure 2.

Cumulative incidence of cancer between statin user and nonuser. Statin user was defined by filled prescription for at least 90 consecutive days of statin use after the index date (the date on which a patient was diagnosed as incident heart failure). Statin nonuser was defined as never use of statin or <90 consecutive days of statin use after the index date. We calculated the P-value using Gray’s test for equality of the cumulative functions between each exposure group after inverse probability of treatment weighting, accounting for competing risks of all-cause mortality. The inset shows the same data on an expanded y-axis.